CA
NVO

Commerzbank Aktiengesellschaft’s Novo Nordisk NVO Stock Holding History

Commerzbank Aktiengesellschaft’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-42,800
Closed -$1.17M – 1155
2015
Q2 		$1.17M Hold
42,800
– – 0.01% 769
2015
Q1 		$1.14M Buy
+42,800
New +$986K 0.01% 759
2014
Q1 		– Sell
-529,000
Closed -$2.1M – 1331
2013
Q4 		$2.1M Buy
529,000
+4,000
+0.8% +$69.7K 0.01% 736
2013
Q3 		$8.88M Buy
+525,000
New +$8.83M 0.04% 304

Other funds holding NVO

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return
EHC
Everett Harris & Co Los Angeles, California $8.14B AUM 14.79% 1-Year Est. Return

Commerzbank Aktiengesellschaft's NVO Position: Q1 2020 in Review

Commerzbank Aktiengesellschaft sold out of Novo Nordisk (NVO) in Q1 2020, closing a stake of 153,506 shares — an estimated $4.44M sold.

Commerzbank Aktiengesellschaft first reported a position in NVO in Q2 2013 and held it in 27 quarters. The position peaked at $20M in Q3 2015. 644 funds tracked by Wall St. Rank hold NVO as of Q1 2020.

  • Commerzbank Aktiengesellschaft reported no remaining Novo Nordisk position as of Q1 2020 after selling out during the quarter.
  • Commerzbank Aktiengesellschaft sold 153,506 Novo Nordisk shares in Q1 2020, an estimated $4.44M.
  • Commerzbank Aktiengesellschaft first reported a position in Novo Nordisk in Q2 2013 and held it in 27 quarters.
  • Commerzbank Aktiengesellschaft's Novo Nordisk position peaked at $20M in Q3 2015.
  • 644 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2020.

Based on Commerzbank Aktiengesellschaft's 13F filing for Q1 2020, filed 29 Apr 2020.